46 min listen
Talking about Alzheimer's disease: current drugs, clinical trials, and the pipeline
Talking about Alzheimer's disease: current drugs, clinical trials, and the pipeline
ratings:
Length:
47 minutes
Released:
Feb 9, 2023
Format:
Podcast episode
Description
Sometimes, there’s an interview that’s just a bit long for the regular podcast. So we’re going to start an occasional series of podcasts where we look a bit more in depth at a condition, and what’s the current state of affairs in treatment. In this podcast, the first, we take a closer look at Alzheimer’s disease with a conversation about current drugs, clinical trials, and the pipeline.Our guest is Sharon L. Rogers, CEO of the biotech AmyriAD Therapeutics.SponsorInterested in sponsoring one or more episodes of the podcast? Learn more here!Leave a review on Apple podcastsReviews are hugely important because they help new people discover this podcast. If you enjoyed listening to this episode, we would love to hear your feedback!Connect with uslabiotech.euSubscribe to our newsletter
Released:
Feb 9, 2023
Format:
Podcast episode
Titles in the series (96)
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma by Beyond Biotech - the podcast from Labiotech